Dasatinib and Dysfunction of Platelets.
作者信息
Sahu Kamal Kant, Yanamandra Uday, Bhar Vikrant, Dhibar Deba Prasad, Varma Subhash Chander, Malhotra Pankaj
机构信息
Department of Clinical Haematology, Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.
出版信息
Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):246-7. doi: 10.1007/s12288-016-0659-x. Epub 2016 Feb 23.
Abstract
摘要
相似文献
1
Dasatinib and Dysfunction of Platelets.达沙替尼与血小板功能障碍
Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):246-7. doi: 10.1007/s12288-016-0659-x. Epub 2016 Feb 23.
2
Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia.达沙替尼可抑制慢性髓性白血病患者的涂层血小板生成。
Platelets. 2019;30(7):836-843. doi: 10.1080/09537104.2018.1501470. Epub 2018 Aug 1.
3
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.达沙替尼诱导血小板功能障碍引发慢性髓性白血病患者胃肠道出血：病例报告
Platelets. 2015;26(8):809-11. doi: 10.3109/09537104.2015.1049138. Epub 2015 Jun 1.
4
[Effect of low-dose dasatinib in an elderly patient with chronic myelogenous leukemia (CML)].低剂量达沙替尼对一名老年慢性髓性白血病（CML）患者的疗效
Gan To Kagaku Ryoho. 2010 Nov;37(11):2213-5.
5
PO-55 - Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors - a way to improve personalized cancer therapy?PO-55-酪氨酸激酶抑制剂引起的止血变化的个体差异 - 改善个体化癌症治疗的一种方法？
Thromb Res. 2016 Apr;140 Suppl 1:S196-7. doi: 10.1016/S0049-3848(16)30188-8. Epub 2016 Apr 8.
6
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.达沙替尼会引发肺血管毒性并易导致肺动脉高压。
J Clin Invest. 2016 Sep 1;126(9):3207-18. doi: 10.1172/JCI86249. Epub 2016 Aug 2.
7
Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling.自噬通过p38信号通路保护细胞免受达沙替尼诱导的肝毒性。
Oncotarget. 2015 Mar 20;6(8):6203-17. doi: 10.18632/oncotarget.3357.
8
Imatinib and Dasatinib Provoke Mitochondrial Dysfunction Leading to Oxidative Stress in C2C12 Myotubes and Human RD Cells.伊马替尼和达沙替尼引发线粒体功能障碍，导致C2C12肌管和人RD细胞中的氧化应激。
Front Pharmacol. 2020 Jul 23;11:1106. doi: 10.3389/fphar.2020.01106. eCollection 2020.
9
Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports.达沙替尼治疗费城染色体阳性B细胞急性淋巴细胞白血病儿童复发性胃肠道出血：病例报告
Case Rep Hematol. 2020 Feb 10;2020:5678210. doi: 10.1155/2020/5678210. eCollection 2020.
10
Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.达沙替尼治疗后血小板计数正常的费城染色体阳性急性淋巴细胞白血病患者发生自发性硬膜下血肿。
Platelets. 2015;26(5):491-4. doi: 10.3109/09537104.2014.935316. Epub 2014 Jul 15.
引用本文的文献
1
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia.肝素诱导的血小板减少症诊断中诊断检测及抗PF4抗体的当前观点
J Blood Med. 2020 Aug 17;11:267-277. doi: 10.2147/JBM.S232648. eCollection 2020.
2
COVID-19 related immune hemolysis and thrombocytopenia.COVID-19 相关免疫性溶血性贫血和血小板减少症。
J Med Virol. 2021 Feb;93(2):1164-1170. doi: 10.1002/jmv.26402. Epub 2020 Aug 16.
本文引用的文献
1
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.达沙替尼诱导血小板功能障碍引发慢性髓性白血病患者胃肠道出血：病例报告
Platelets. 2015;26(8):809-11. doi: 10.3109/09537104.2015.1049138. Epub 2015 Jun 1.
2
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.接受二线尼罗替尼或达沙替尼治疗的慢性髓性白血病患者严重血管事件及其他非血液学并发症的真实世界比较。
Leuk Lymphoma. 2015;56(8):2309-14. doi: 10.3109/10428194.2014.994205. Epub 2015 Mar 5.
3
Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.达沙替尼治疗后血小板计数正常的费城染色体阳性急性淋巴细胞白血病患者发生自发性硬膜下血肿。
Platelets. 2015;26(5):491-4. doi: 10.3109/09537104.2014.935316. Epub 2014 Jul 15.
4
Platelet function tests: a review of progresses in clinical application.血小板功能检测：临床应用进展综述。
Biomed Res Int. 2014;2014:456569. doi: 10.1155/2014/456569. Epub 2014 May 8.
5
Dietary manipulation of platelet function.饮食对血小板功能的影响。
Pharmacol Ther. 2014 Nov;144(2):97-113. doi: 10.1016/j.pharmthera.2014.05.008. Epub 2014 May 21.
6
[Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].[接受酪氨酸激酶抑制剂治疗的慢性粒细胞白血病患者的肠道出血]
Rinsho Ketsueki. 2014 Jan;55(1):130-2.
7
The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.阿司匹林和鱼油消费对成年糖尿病患者溶血磷脂酰胆碱和溶血磷脂酸及其与血小板聚集的影响。
Prostaglandins Leukot Essent Fatty Acids. 2014 Feb-Mar;90(2-3):61-8. doi: 10.1016/j.plefa.2013.12.004. Epub 2013 Dec 18.
8
[Effect of low-dose dasatinib in an elderly patient with chronic myelogenous leukemia (CML)].低剂量达沙替尼对一名老年慢性髓性白血病（CML）患者的疗效
Gan To Kagaku Ryoho. 2010 Nov;37(11):2213-5.
9
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.酪氨酸激酶抑制剂伊马替尼、达沙替尼和尼洛替尼的药物相互作用。
Blood. 2011 Feb 24;117(8):e75-87. doi: 10.1182/blood-2010-07-294330. Epub 2010 Sep 1.
10
Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia.酪氨酸激酶抑制剂诱发慢性髓性白血病患者的血小板功能障碍。
Blood. 2009 Jul 9;114(2):261-3. doi: 10.1182/blood-2008-09-180604. Epub 2009 May 4.
Zotero 插件